Xenetic Biosciences doses first patient in DNase and CAR T-cell study
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
| Xenetic Biosciences, Inc. (NASDAQ: XBIO) | Delayed: 1.93 -0.09 (4.46%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.02 | 52 Week High | $5.20 | |||
| Open | $2.03 | 52 Week Low | $0.21 | |||
| Day High | $2.04 | P/E | N/A | |||
| Day Low | $1.90 | EPS | $-0.01 | |||
| Volume | 18,881 | |||||
